Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTIS2022-501570-18-00
CTIS2022-501570-18-00RecruitingPhase 1

D9350C00001

Astrazeneca AB0 sites626 target enrollmentStarted: February 28, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Enrollment
626
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 65+ (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Similar Trials

Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT06762340[Redacted]
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT04945941[Redacted]
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT06733259[Redacted]
Completed
Not Applicable
Clinical Investigation (Beta) of a New Developed Prosthetic Knee
NCT06748729Össur Iceland ehf11
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT06422065[Redacted]